Events & Presentations
Upcoming Events
- Upcoming Events
- Archive
-
May 2, 2024Publication of the Interim Report for the First Quarter 2024 (after 5:00 PM CEST)Aug 1, 2024Publication of the Interim Report for the First Half 2024 (after 5:00 PM CEST)Nov 6, 2024Publication of the Interim Report for the First Nine Months 2024 (after 5:00 PM CET)Dec 31, 2024Financial Calendar Year End
-
Apr 3, 2024 at 7:00 AM EDTInvestor Call on Proposed Acquisition of ProfoundBio
Genmab held a conference call to discuss its proposed acquisition of ProfoundBio on April 3.
Mar 13, 2024Annual General Meeting 2024For more information about the 2024 Annual General Meeting, please click here.Feb 14, 2024Publication of the Annual Report for 2023 (after 5:00 PM CET)On February 14, Genmab announced its full year 2023 financial results.
Jan 30, 2024Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 10, 2024 from 11:15 AM to 11:55 AM PST42nd Annual J.P. Morgan Healthcare ConferenceDec 31, 2023Financial Calendar Year EndDec 12, 2023 at 11:00 AM EST2023 R&D Update and ASH Data ReviewGenmab will host its 2023 R&D Update and ASH Data Review virtually on Tuesday, December 12, 2023.
This meeting is not an official program of the ASH Annual Meeting.
Nov 16, 2023 at 11:00 AM CETJefferies Healthcare ConferenceFireside Chat with Chief Executive Officer, Jan van de Winkel, and Chief Financial Officer, Anthony Pagano.Nov 7, 2023Publication of the Interim Report for the first nine months 2023Genmab announced its financial results for the first nine months of 2023 on November 7, 2023.
Sep 12, 2023 at 3:35 PM EDTMorgan Stanley 21st Annual Global Healthcare ConferenceFireside Chat with Chief Executive Officer Jan van de Winkel and Chief Financial Officer Anthony Pagano.Aug 3, 2023Publication of the Interim Report for the first half 2023 (after 5:00 PM CEST)Jun 13, 2023 at 2:20 PM EDTGoldman Sachs 44th Annual Global Healthcare ConferenceFireside Chat with Chief Financial Officer, Anthony Pagano.May 10, 2023Publication of the Interim Report for the first quarter 2023 (after 5:00 PM CEST)Mar 29, 2023Annual General Meeting 2023Genmab A/S’ 2023 Annual General Meeting took place on Wednesday, March 29, 2023.Feb 22, 2023Publication of the Annual Report for 2022On February 22, Genmab announced its full year 2022 financial results.
Feb 14, 2023Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of DirectorsJan 11, 2023 from 9:00 AM to 9:40 AM PST41st Annual J.P. Morgan Healthcare Conference -
-